Different outcomes in sporadic versus familial medullary thyroid cancer.
Katerina SaltikiGeorge SimeakisElli AnagnostouEvangelia ZapantiEleni AnastasiouMaria AlevizakiPublished in: Head & neck (2018)
After excluding genetic screening cases, although stage at diagnosis is similar, disease outcome remains worse in sporadic compared to fMTCs.